Live data from Hacker News

Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

merck.com

1–10 of 294 posts

Re: Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

#2
If you want to read a comment on this, try Derek Lowe's:

https://www.science.org/content/blog-post/molnupiravir-thor-...

Wikipedia has an article on the drug already if you would like to have a look at that instead:

https://en.wikipedia.org/wiki/Molnupiravir

Re: Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

#7
post #6

Will this affect mandate requirements, if as effective as it’s claimed? If so we don't need to reach hard to achieve 95% vaccination rates and we can get closer to a normal life.

If it halves hospitalizations, it'll have a pretty drastic effect on overwhelmed ICUs but there's probably still a ways to go before ICU levels return to normal and we can skip mandates.

Re: Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

#8
post #6

Will this affect mandate requirements, if as effective as it’s claimed? If so we don't need to reach hard to achieve 95% vaccination rates and we can get closer to a normal life.

If it’s patented and they can make real money off it, maybe

Re: Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

#9
post #5

If I understand things correctly, this only helps _before_ hospitalization.

The trial was on non-hospitalized patients, because you can't test impact on hospitalization risk with patients that are already hospitalized. But given the supposed mechanism of action, I don't think there's any reason to believe it would not also be an effective therapy for hospitalized patients.
Post reply on HN